Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT.
Southampton (UK): National Institute for Health and Care Research; 2022 May.
Southampton (UK): National Institute for Health and Care Research; 2022 May.
PMID: 35679443
Free Books & Documents.
Review.
Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial.
Turner S, Cotton S, Wood J, Bell V, Raja EA, Scott NW, Morgan H, Lawrie L, Emele D, Kennedy C, Scotland G, Fielding S, MacLennan G, Norrie J, Forrest M, Gaillard EA, de Jongste J, Pijnenburg M, Thomas M, Price D.
Turner S, et al. Among authors: emele d.
Lancet Respir Med. 2022 Jun;10(6):584-592. doi: 10.1016/S2213-2600(21)00486-0. Epub 2022 Jan 31.
Lancet Respir Med. 2022.
PMID: 35101183
Clinical Trial.
Item in Clipboard
Cite
Cite